|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Maki Umemura (Cardiff University, UK)Publisher: Taylor & Francis Ltd Imprint: Routledge Weight: 0.380kg ISBN: 9781138481435ISBN 10: 1138481432 Pages: 190 Publication Date: 25 April 2018 Audience: College/higher education , Tertiary & Higher Education Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1. Introduction: Why didn’t Japan become a global leader in pharmaceuticals? 2. A historical overview of Japan’s pharmaceutical industry 3. Developing a modern industry: The antibiotics sector 4. What went wrong? The anticancer drug sector 5. Conclusion: Reconsidering Japan’s business in pharmaceuticalsReviews'The Japanese Pharmaceutical Industry is an ambitious, broad-ranging analysis of the postwar history of an industry whose eight per cent share of Japanese manufacturing understates its significance in terms of health and as a barometer for science-based innovation.' - Robert Kneller, University of Tokyo; Journal of Japanese Studies, 2013. Author InformationMaki Umemura is a lecturer in Japanese studies at Cardiff Business School, Cardiff University, UK. Tab Content 6Author Website:Countries AvailableAll regions |